Structural details of an attractive drug target in coronaviruses that could be used against SARS-CoV-2 and in future pandemics have been published today in eLife.
Nov 22, 2022
0
66
Northwestern Medicine scientists have discovered the pathways through which autoantibodies—immune proteins that mistakenly attack a person's own body—leak out of blood vessels and cause primary graft dysfunction in some ...
Nov 18, 2022
0
12
Researchers at the University of Maryland School of Medicine's (UMSOM) Center for Precision Disease Modeling identified how a specific protein in SARS-CoV-2, the virus responsible for COVID-19, damages heart tissue. They ...
Nov 8, 2022
0
61
Scientists at the UNC School of Medicine and UNC Eshelman School of Pharmacy, in collaboration with a team from Queen Mary University of London, have illuminated the molecular events underlying an inherited movement and ...
Nov 3, 2022
0
151
Viruses and bacteria have a very long history. Because viruses can't reproduce without a host, they've been attacking bacteria for millions of years. Some of those bacteria eventually became mitochondria, synergistically ...
Oct 31, 2022
0
154
More than 40 years into the HIV pandemic, scientists are still turning up clues revealing how the virus hijacks its host's cellular processes to support its own replication—and promote the long-term survival of the virus ...
The emergence of SARS-CoV-2 (the virus that causes COVID) has changed the world as we know it. Although new vaccines and antiviral treatments have brought hope, the pesky virus has continued to mutate and evade us.
Oct 26, 2022
0
8
The discovery of a genetic variant that is relatively common among people of Polynesian ancestry, but incredibly rare in most other populations, is giving clues to the genetic underpinnings of high cholesterol in all people, ...
Oct 20, 2022
0
48
A study led by an Oregon State University pharmaceutical sciences researcher has produced a proof of principle for a new "universal" means of treating COVID-19.
Oct 18, 2022
0
38
Alzheimer's disease (AD) currently has no cure and is predicted to affect over 100 million people worldwide by 2050. Ongoing research is focused on two key neurotoxic proteins: amyloid beta (Aβ) and tau. While these proteins ...
Oct 17, 2022
0
16
